Compared to the above two publications, our meta-analysis summarized 22 eligible case-control studies with a larger sample size and offered convincing evidence by systematically analyzing the association of IBD susceptibility with two DLG5 polymorphisms, including not only the most studied variant, R30Q, but also another significant variant, P1371Q. Here, DLG5 is linked to inflammatory bowel disease.